Democratic Leader Pelosi, Democratic Whip Hoyer, Rep. Waxman, Rep. Obey, Rep. Rangel, Rep. George Miller, Rep. Levin, and Rep. DeLauro raise concerns that the Social Security Administration’s 2005 communications plan could violate the prohibition on publicity and propaganda by promoting the message that Social Security is facing a collapse.
Rep. Waxman, joined by 19 other members of Congress, requests that GAO review HHS's processes for determining the accuracy and evaluating the effectiveness of "abstinence-only" education programs.
Rep. Waxman and Homeland Security Committee Ranking Member Bennie Thompson ask Secretary Ridge to disclose contacts between top Department of Homeland Security officials and Blank Rome, a firm that lobbies the department extensively for federal contracts.
In a letter to the Consumer Products Safety Commission, Rep. Waxman calls for strengthened standards to protect children from dangerous levels of lead in toy jewelry and other children's products.
Rep. Waxman and Rep. Conyers ask GAO to investigate the long lines and excessive waiting times experienced by voters in the 2004 election.
In light of recent incidents in which taxpayer funds have been improperly used to influence public opinion, Democratic Leader Pelosi, Rep. Waxman, and six other senior members of Congress ask GAO to examine the use of covert propaganda by departments and agencies under the Bush Administration.
Rep. Waxman asks GAO to investigate aspects of the prescription drug discount card program established under the new Medicare law, including the selection of sponsoring organizations and the value of the cards for beneficiaries.
Rep. Waxman and nine other members of Congress ask CDC, NIAID, USAID, and the White House Global AIDS Coordinator if they support a consensus statement on the prevention of sexual transmission of HIV recently signed by more than 130 religious, political, health and scientific leaders from across the developed and developing world.
Democratic Leader Pelosi, Rep. Waxman, Rep. George Miller, Rep. Obey, and Rep. Cummings write the President about three recent incidents in which taxpayer funds have been improperly used by Administration officials to pay for covert efforts to influence public opinion.
Rep. Waxman and Sen. Conrad ask Agriculture nominee Michael Johanns to reconsider the decision to allow cattle imports from Canada in light of new information that cattle feed in Canada may be contaminated with animal protein, risking the spread of “mad cow disease.”
Rep. Waxman and Chairman Davis write Secretary Thompson to object to a plan to use CDC's child immunization funds to purchase flu vaccine from abroad.
Despite nine critical government audits, whistleblower testimony describing egregious overbilling, and criminal investigations into kickbacks and overcharging, Halliburton has been awarded $10.8 billion under its Iraq contracts.
Rep. Waxman requests a GAO investigation into AIDS prevention activities funded by the President's Emergency Plan for AIDS Relief (PEPFAR).
Reps. Waxman, Obey, and Dingell describe their concerns with a new ethics policy that restricts the right of members to criticize the Ethics Committee.
Acting FDA Commissioner Dr. Lester Crawford's testimony maintained that FDA made no mistakes that contributed to the flu vaccine crisis, but a review of the record reveals conflicting evidence from FDA documents, statements made by senior FDA staff, and basic facts about FDA's regulatory system.
Rep. Waxman and Chairman Davis request information on NIH's policies regarding conflicts of interest for researchers who receive NIH grants and scientists who review grant proposals.
Rep. Waxman asks FDA to review the discrepancy between claims made by AstraZeneca that FDA has “no concern” about the safety of the drug Crestor, in light of top FDA officials’ statements that FDA is “very concerned” and is closely evaluating the drug.
A report released by Rep. Waxman shows that many federally funded abstinence-only education programs use curricula that distort information about the effectiveness of contraceptives, misrepresent the risks of abortion, blur religion and science, treat stereotypes about girls and boys as scientific fact, and contain basic scientific errors.
New FDA documents raise serious questions about the agency’s oversight of the Chiron facility that was scheduled to deliver half of the nation’s flu shot supply this year.
Rep. Waxman calls for hearings into new State Department documents that disclose efforts by senior Administration officials, including the Ambassador to Kuwait, to steer a lucrative Halliburton fuel subcontract to a favored Kuwaiti company. The documents also describe allegations of widespread bribes and kickbacks sought by Halliburton officials.
Rep. Waxman asks FDA Commissioner Crawford to respond to a confidential communication received from inside his agency indicating that the Commissioner’s office is withholding documents that address whether the flu vaccine crisis could have been prevented.
Rep. Waxman writes Senate Majority Leader Frist and House Speaker Hastert to urge them to reject a last-minute effort to insert provisions undermining financial disclosure laws in the 9/11 legislation.
Rep. Waxman criticizes FDA for failing to release key documents about whether the flu vaccine crisis could have been prevented and asks Chairman Davis to issue an immediate subpoena.
A new report released by Rep. Waxman finds that the President has repeatedly appointed individuals with Republican political backgrounds to serve as nonpartisan Inspectors General at federal departments and agencies.
Reps. Waxman and Maloney ask GAO to investigate whether the Defense Department is fulfilling its obligation to ensure that Americans living abroad, both military and civilian, can vote.
Displaying Items 926 to 950 of 1458:
[1] • [2] • [3] • [4] • [5] • [6] • [7] • [8] • [9] • [10] • [11] • [12] • [13] • [14] • [15] • [16] • [17] • [18] • [19] • [20] • [21] • [22] • [23] • [24] • [25] • [26] • [27] • [28] • [29] • [30] • [31] • [32] • [33] • [34] • [35] • [36] • [37] • [38] • [39] • [40] • [41] • [42] • [43] • [44] • [45] • [46] • [47] • [48] • [49] • [50] • [51] • [52] • [53] • [54] • [55] • [56] • [57] • [58] • [59]